IgG4-Related Chronic Sclerosing Dacryoadenitis.

M. Takahira,M. Kawano,Y. Zen,H. Minato,Kazunori Yamada,K. Sugiyama

DOI: https://doi.org/10.1001/ARCHOPHT.125.11.1575

2007-11-01

A M A Archives of Ophthalmology

Abstract:

What problem does this paper attempt to address?

Estimation of cancer mortality attributable to excess body weight during 2006-2015 in China

Lisha Xu,Zongming Yang,Tiezheng Li,Luhua Yu,Zhanghang Zhu,Yonghao Wu,Mengling Tang,Mingjuan Jin,Kun Chen,Jianbing Wang

DOI: https://doi.org/10.21203/rs.3.rs-1875897/v1

2022-01-01

Abstract:Abstract Background: Cancer is one of the most common causes of death. Excess body weight (including overweight and obesity), a risk factor of cancer, is highly prevalent in China. We aimed to estimate the number and proportion of cancer deaths attributed to excess body weight and their changes from 2006 to 2015 in China.Methods: We calculated the proportion of cancer deaths attributed to excess body weight during 2006-2015 in China. Population attributable fraction (PAF) was calculated with: 1) prevalence of overweight/obesity, exacted from the China Health and Nutrition Survey conducted in 1997, 2000, and 2004; 2) relative risks (RRs) for excess body weight and site-specific cancers, obtained from published studies; 3) data on cancer deaths in 2006, 2010, and 2015, originated from the Chinese Cancer Registry Annual Report.Results: In 2015, excess body weight contributed to 45,385 cancer deaths (3.17% of all) in China. The highest fraction of cancer deaths attributable to excess body weight was in the northeast (4.18%, 95% CI: 1.44-7.22%), whereas the lowest one was in the west (1.69%, 95%CI: 0.55-3.03%). The fractions of cancer deaths attributable to excess body weight were higher in women than that in men (2.12% VS. 1.73% for overweight; 1.68% VS. 0.92% for obesity). During 2006 - 2015, the overall PAF attributed to overweight decreased slightly and then increased, whereas the corresponding figure was on the rise for obesity.Conclusion: Proportion of cancer deaths attributed to excess body weight was higher in women, and subjects in the east and northeast, and was on an upward trend in recent decades. A combination of comprehensive and individualized measures is necessary to reduce the prevalence of excess body weight and related cancer burden in China.
Estimation of Cancer Mortality Attributable to Excess Body Weight During 2006-2015 in China.

Lisha Xu,Zongming Yang,Tiezheng Li,Luhua Yu,Zhanghang Zhu,Yonghao Wu,Mengling Tang,Mingjuan Jin,Kun Chen,Jianbing Wang

DOI: https://doi.org/10.1016/j.canep.2023.102358

IF: 2.89

2023-01-01

Cancer Epidemiology

Abstract:BACKGROUND:Cancer is one of the most common causes of death. Excess body weight (EBW), a risk factor for cancer, is highly prevalent in China. We aimed to estimate the number and proportion of cancer deaths attributed to EBW and their changes during 2006-2015 in China.METHODS:Population attributable fractions in 2006, 2010, and 2015 were calculated with 1) prevalence of overweight/obesity, exacted from the China Health and Nutrition Survey conducted in 8-9 provinces of China in 1997, 2000, and 2004; 2) relative risks for EBW and site-specific cancers, obtained from previous studies; 3) data on cancer deaths in 2006, 2010, and 2015, originated from the Chinese Cancer Registry Annual Report.RESULTS:In 2015, EBW contributed to 45,918 (3.1% of all) cancer deaths in China, with 24,978 (2.6%) in men and 20,940 (3.8%) in women. By region, the fraction of cancer deaths attributable to EBW ranged from 1.6% (West) to 4.1% (Northeast). Cancers of liver, stomach, and colorectum were the main EBW-attributable cancers. The fractions of cancer deaths attributable to EBW were 2.4% (95%CI: 0.8-4.2%) in 2006, 2.9% (95%CI: 1.0-5.2%) in 2010, and 3.1% (95%CI: 1.0-5.4%) in 2015, respectively, and increased for all gender, region, and cancer site during 2006-2015.CONCLUSIONS:The proportion of cancer deaths attributed to EBW was higher in women and Northeastern China, with an upward trend in the recent decade. A combination of comprehensive and individualized measures is necessary to reduce the prevalence of EBW and related cancer burden in China.
Global Trends in Incidence, Death, Burden and Risk Factors of Early-Onset Cancer from 1990 to 2019

Malcolm Dunlop,Jing Sun,Lijuan Wang,Xue Li,Mingyang Song,Harry Campbell,Evropi Theodoratou,Shuai Yuan,Igor Rudan,Yingshuang Zhu,Kefeng Ding,Jianhui Zhao,Susanna Larsson,Liying Xu,Zhengwei Wan,Konstantinos Tsilidis,Peige Song

DOI: https://doi.org/10.1136/bmjonc-2023-000049

2023-01-01

Abstract:Objective This study aimed to explore the global burden of early-onset cancer based on the Global Burden of Disease (GBD) 2019 study for 29 cancers worldwid.Methods and analysis Incidence, deaths, disability-adjusted life years (DALYs) and risk factors for 29 early-onset cancer groups were obtained from GBD.Results Global incidence of early-onset cancer increased by 79.1% and the number of early-onset cancer deaths increased by 27.7% between 1990 and 2019. Early-onset breast, tracheal, bronchus and lung, stomach and colorectal cancers showed the highest mortality and DALYs in 2019. Globally, the incidence rates of early-onset nasopharyngeal and prostate cancer showed the fastest increasing trend, whereas early-onset liver cancer showed the sharpest decrease. Early-onset colorectal cancers had high DALYs within the top five ranking for both men and women. High-middle and middle Sociodemographic Index (SDI) regions had the highest burden of early-onset cancer. The morbidity of early-onset cancer increased with the SDI, and the mortality rate decreased considerably when SDI increased from 0.7 to 1. The projections indicated that the global number of incidence and deaths of early-onset cancer would increase by 31% and 21% in 2030, respectively. Dietary risk factors (diet high in red meat, low in fruits, high in sodium and low in milk, etc), alcohol consumption and tobacco use are the main risk factors underlying early-onset cancers.Conclusion Early-onset cancer morbidity continues to increase worldwide with notable variances in mortality and DALYs between areas, countries, sex and cancer types. Encouraging a healthy lifestyle could reduce early-onset cancer disease burden.
Control of oxidative stress in small bowel: relevance to organ preservation.

P. Salehi,John R. Walker,K. Madsen,T. Churchill

DOI: https://doi.org/10.1016/J.SURG.2005.08.003

IF: 4.348

2006-03-01

Surgery

Abstract:
1706-P: Obesity-Related Cancer Increased Sharply in Young Adults among Chinese Population from 2007 to 2021

JIN-KUI YANG,CHANG LIU,YINGCHAO YUAN

DOI: https://doi.org/10.2337/db23-1706-p

IF: 7.7

2023-06-20

Diabetes

Abstract:Objective: The burden of obesity-related cancer has rarely been investigated. This study aims to investigate the trends of incidence of obesity-related cancer in a Chinese population. Method: During 2007-2021, a population-based registry of cancer covering 14.14 million people was performed in 207 medical sites by the Beijing Municipal Health Commission Information Center. We compared the trends of incidence of obesity-related cancers and non-obesity-related cancer. Results: Overall, there were 651,482 incident cancer patients in this population from 2007 to 2021. Of these patients, 48.49% were obesity-related cancers. For all obesity-related cancers combined, the age-standardized incidence rates (ASR) showed a significant upward trend (3.6% per year, P< 0.001). Conversely, for non-obesity-related cancers, the ASR was stable during this period (Fig.1 Age-specific differences of all cancers: A,B: annual changes; C,D: incidence rate ratio; E,F: incidence). We predict that the ASR for obesity-related cancers will increase 2.62-fold in 2035 compared to 2021, and will increase mainly in people younger than 50 and decrease in those over 75 years. Conclusion: Obesity-related cancer incidence significantly increased from 2007 to 2021. While most cases were diagnosed in old people, the obesity-related incidence increased sharply in young adults. These will increase the burden of cancer in the future. Disclosure J.Yang: None. C.Liu: None. Y.Yuan: None. Funding National Natural Science Foundation of China (81930019)

endocrinology & metabolism
Rising incidence of obesity-related cancers among younger adults in China: A population-based analysis (2007-2021)

Chang Liu,Ying-Chao Yuan,Mo-Ning Guo,Zhong Xin,Guan-Jie Chen,Nan Ding,Jian-Peng Zheng,Bai Zang,Jin-Kui Yang

DOI: https://doi.org/10.1016/j.medj.2024.07.012

2024-11-08

Med

Abstract:Background: Developing countries face an "obesity epidemic," particularly affecting children and younger adults. While obesity is a known risk factor for 12 types of cancer, primarily affecting older populations, its impact on younger generations is understudied. Methods: This study analyzed data from a population-based cancer registry covering 14.14 million individuals in China (2007-2021). We compared the incidence of obesity- and non-obesity-related cancers and applied an age-period-cohort model to estimate their impacts. Findings: Among 651,342 cancer cases, 48.47% were obesity related. The age-standardized incidence rates (ASRs) of the 12 obesity-related cancers increased annually by 3.6% (p < 0.001), while ASRs for non-obesity-related cancers remained stable. Obesity-related cancers surged among younger adults, with rates rising across successive generations. The annual percentage of change decreased with age, from 15.28% for ages 25-29 years to 1.55% for ages 60-64 years. The incidence rate ratio for obesity-related cancer was higher in younger generations compared to those born in 1962-1966. We predict that the ASR for obesity-related cancers will nearly double in the next decade. Conclusions: The rising incidence of obesity-related cancers among young adults poses a significant public health concern. The increasing cancer burden underscores the need for targeted interventions to address the obesity epidemic. Funding: This work was supported by the National Natural Science Foundation of China (81930019, 82341076) to J.-K.Y.
Estimation of Cancer Incidence and Mortality Attributable to Overweight, Obesity, and Physical Inactivity in China.

Ding Wang,Wei Zheng,Shao-Ming Wang,Jian-Bing Wang,Wen-Qiang Wei,Hao Liang,You-Lin Qiao,Paolo Boffetta

DOI: https://doi.org/10.1080/01635581.2012.630166

2012-01-01

Nutrition and Cancer

Abstract:The objective was to provide an evidence-based, systematic assessment of the burden of cancer due to overweight/obesity and physical inactivity in China. This study evaluated the proportion of cancers of colon, rectum, pancreas, breast (postmenopausal), endometrium, and kidney attributable to overweight [30 kg/m(2) > body mass index (BMI) ≥ 25 kg/m(2))/obesity (BMI ≥ 30 kg/m(2)) and physical inactivity in China in 2005. Data of prevalence of overweight/obesity and lack of physical activity were derived from cross-sectional surveys among representative samples of Chinese population, and data of relative risks on cancers were derived from meta-analyses or large-scale studies from China and East Asian populations. The attributable fractions were calculated by combining both data of prevalence and relative risks. In China in 2005, 0.32% of cancer deaths and 0.65% of cancer cases were attributable to overweight and obesity combined. Lack of physical activity was responsible for 0.27% of cancer deaths and 0.39% of cancer cases. Future projections indicate that the contribution of overweight and obesity to the overall cancer burden will increase in the next decades. The largest increased attributable fractions will be for endometrial cancer. The increase in attributable fractions would be greater in men and in rural populations. Although the current burden of cancer associated with overweight/obesity and physical inactivity is still relatively small in China, it is expected to increase in the future.
The impacts of exposure to risk factors during youth on the increasing global trend of early-onset pancreatic cancer

J. Cai,B. Lu,H. Chen,M. Lu,Y. Zhang,C. Luo,L. You,M. Dai,Y. Zhao

DOI: https://doi.org/10.1016/j.puhe.2023.11.006

IF: 4.984

2024-02-25

Public Health

Abstract:Objectives An increasing trend of pancreatic cancer in young adults has emerged in some countries. This study aimed to investigate global trends of pancreatic cancer in young adults and explore the impact of exposure to risk factors on pancreatic cancer incidence during youth. Methods Global and national data on pancreatic cancer incidence, disability-adjusted life-years, attributive mortality, and summary exposure values of risk factors were retrieved from the Global Burden of Disease 2019. The average annual percent change (AAPC) of incidence and mortality was calculated. Additionally, generalized additive models were applied to explore the non-linear associations between the levels and changes in the Human Development Index and AAPC. Results Global pancreatic cancer incidence increased during various periods from 1990 to 2019, particularly in adults aged <45 years from 2010 to 2019, at an average annual increase rate of 0.7% (95% confidence interval: 0.4–1.0%). The AAPC of early-onset pancreatic cancer incidence from 2010 to 2019 was negatively correlated with Human Development Index levels in both 2010 and 2019 but positively correlated with Human Development Index acceleration. Significant increases in early-onset pancreatic cancer incidence were observed over this period in 32 of 88 countries, primarily in South America, North America, Oceania, and Africa. Early-onset pancreatic cancer mortality attributed to high body mass index and fasting plasma glucose increased, while that attributed to tobacco use declined. Conclusions An increasing trend has emerged in the global incidence and burden of early-onset pancreatic cancer over the last few decades. This rise may partly be attributed to global epidemics of high body mass index and fasting plasma glucose.

public, environmental & occupational health
Plasma fibrinogen and serum C-reactive protein are associated with non-small cell lung cancer.

J. M. Jones,N. McGonigle,Martin McAnespie,G. Cran,A. Graham

DOI: https://doi.org/10.1016/J.LUNGCAN.2006.03.012

IF: 6.081

2006-07-01

Lung Cancer

Abstract:
Obesity, obesities and gastrointestinal cancers

Yuntao Zou,Capecomorin S Pitchumoni

DOI: https://doi.org/10.1016/j.disamonth.2023.101592

Abstract:Obesity has been recognized to be increasing globally and is designated a disease with adverse consequences requiring early detection and appropriate care. In addition to being related to metabolic syndrome disorders such as type 2 diabetes, hypertension, stroke, and premature coronary artery disease. Obesity is also etiologically linked to several cancers. The non-gastrointestinal cancers are breast, uterus, kidneys, ovaries, thyroid, meningioma, and thyroid. Gastrointestinal (GI) cancers are adenocarcinoma of the esophagus, liver, pancreas, gallbladder, and colorectal. The brighter side of the problem is that being overweight and obese and cigarette smoking are mostly preventable causes of cancers. Epidemiology and clinical studies have revealed that obesity is heterogeneous in clinical manifestations. In clinical practice, BMI is calculated by dividing a person's weight in kilograms by the square of the person's height in square meters (kg/m2). A BMI above 30 kg/m2 (defining obesity in many guidelines) is considered obesity. However, obesity is heterogeneous. There are subdivisions for obesity, and not all obesities are equally pathogenic. Adipose tissue, in particular, visceral adipose tissue (VAT), is endocrine and abdominal obesity (a surrogate for VAT) is evaluated by waist-hip measurements or just waist measures. Visceral Obesity, through several hormonal mechanisms, induces a low-grade chronic inflammatory state, insulin resistance, components of metabolic syndrome, and cancers. Metabolically obese, normal-weight (MONW) individuals in several Asian countries may have BMI below normal levels to diagnose obesity but suffer from many obesity-related complications. Conversely, some people have high BMI but are generally healthy with no features of metabolic syndrome. Many clinicians advise weight loss by dieting and exercise to metabolically healthy obese with large body habitus than to individuals with metabolic obesity but normal BMI. The GI cancers (esophagus, pancreas, gallbladder, liver, and colorectal) are individually discussed, emphasizing the incidence, possible pathogenesis, and preventive measures. From 2005 to 2014, most cancers associated with overweight and Obesity increased in the United States, while cancers related to other factors decreased. The standard recommendation is to offer or refer adults with a body mass index (BMI) of 30 or more to intensive, multicomponent behavioral interventions. However, the clinicians have to go beyond. They should critically evaluate BMI with due consideration for ethnicity, body habitus, and other factors that influence the type of obesity and obesity-related risks. In 2001, the Surgeon General's ``Call to Action to Prevent and Decrease Overweight and Obesity'' identified obesity as a critical public health priority for the United States. At government levels reducing obesity requires policy changes that improve the food and physical activity for all. However, implementing some policies with the most significant potential benefit to public health is politically tricky. The primary care physician, as well as subspecialists, should identify overweight and Obesity based on all the variable factors in the diagnosis. The medical community should address the prevention of overweight and Obesity as an essential part of medical care as much as vaccination in preventing infectious diseases at all levels- from childhood, to adolescence, and adults.
Environmental drivers of the rising incidence of early‐onset colorectal cancer in the United States

Jianjiu Chen,Mary Beth Terry,Piero Dalerba,Chin Hur,Jianhua Hu,Wan Yang

DOI: https://doi.org/10.1002/ijc.34887

2024-02-11

International Journal of Cancer

Abstract:What's new? The underlying causes of the rising incidence of early‐onset (diagnosed before age 50) colorectal cancer (EOCRC) in the United States remain largely unclear. Here, by investigating the associations of EOCRC with 11 environmental exposures on the population level, we identified excess body weight as the strongest risk factor, and estimated that excess body weight contributed to about 30% of EOCRC incidence during 1992 to 2016. Our findings suggest that prevention of excess body weight may help curb the EOCRC epidemic. Incidence of early‐onset (diagnosed before age 50) colorectal cancer (EOCRC) has increased alarmingly since the 1990s in the United States. This study investigated what environmental exposures may have driven this increase. We obtained EOCRC incidence data from the Surveillance, Epidemiology, and End Results Program, and data for 11 exposures, for example, body mass index (BMI), from long‐term national surveys. We aggregated these data for 30 to 49‐year‐olds during 1992 to 2016 by population subgroups defined by calendar period, age, race and sex, and used negative binomial regression models to identify and estimate associations of EOCRC with multiple exposures. Furthermore, we used counterfactual modeling to quantify contributions of identified risk factors to EOCRC incidence. The top models (with lowest Bayesian Information Criteria) consistently identified excess body weight, represented by overweight and obesity (BMI ≥25) or obesity alone (BMI ≥30), as the strongest risk factor. The best‐performing model estimated increased EOCRC incidence due to overweight and obesity, with an incidence rate ratio (95% confidence interval) of 1.20 (1.17‐1.22) for white men, 1.04 (1.00‐1.08) for black men, 1.17 (1.15‐1.21) for white women and 1.03 (0.97‐1.08) for black women. Increases in overweight and obesity prevalence contributed to an estimated 30% (standard error: 1%) for men and 28% (standard error: 2%) for women of ECORC incidence during 1992 to 2016. These findings suggest excess body weight substantially contributed to and is likely a primary driver of the rising incidence of EOCRC in the United States. Prevention of excess weight gain may help lower colorectal cancer risk early in life.

oncology
Is early-onset cancer an emerging global epidemic? Current evidence and future implications

Tomotaka Ugai,Naoko Sasamoto,Hwa-Young Lee,Mariko Ando,Mingyang Song,Rulla M. Tamimi,Ichiro Kawachi,Peter T. Campbell,Edward L. Giovannucci,Elisabete Weiderpass,Timothy R. Rebbeck,Shuji Ogino

DOI: https://doi.org/10.1038/s41571-022-00672-8

2022-09-07

Pathogenesis

Abstract:Over the past several decades, the incidence of early-onset cancers, often defined as cancers diagnosed in adults <50 years of age, in the breast, colorectum, endometrium, oesophagus, extrahepatic bile duct, gallbladder, head and neck, kidney, liver, bone marrow, pancreas, prostate, stomach and thyroid has increased in multiple countries. Increased use of screening programmes has contributed to this phenomenon to a certain extent, although a genuine increase in the incidence of early-onset forms of several cancer types also seems to have emerged. Evidence suggests an aetiological role of risk factor exposures in early life and young adulthood. Since the mid-20th century, substantial multigenerational changes in the exposome have occurred (including changes in diet, lifestyle, obesity, environment and the microbiome, all of which might interact with genomic and/or genetic susceptibilities). However, the effects of individual exposures remain largely unknown. To study early-life exposures and their implications for multiple cancer types will require prospective cohort studies with dedicated biobanking and data collection technologies. Raising awareness among both the public and health-care professionals will also be critical. In this Review, we describe changes in the incidence of early-onset cancers globally and suggest measures that are likely to reduce the burden of cancers and other chronic non-communicable diseases. The incidence of early-onset forms of many cancers (defined as cancers diagnosed in individuals <50 years of age) has increased in a number of countries over the past several decades. The underlying reasons for this apparent increase probably include greater use of screening programmes, but also changing patterns in early-life exposures. In this Review, the authors describe the emerging global increase in the incidence of early-onset cancers and suggest changes that might address this situation.

English Else
The Burden of Overweight and Obesity-associated Gastrointestinal Cancers in Low and Lower-middle Income Countries: A Global Burden of Disease 2019 Analysis

Pojsakorn Danpanichkul,Thanida Auttapracha,Banthoon Sukphutanan,Cheng Han Ng,Phuuwadith Wattanachayakul,Siwanart Kongarin,Priyata Dutta,Kwanjit Duangsonk,Jerapas Thongpiya,Mark D. Muthiah,Daniel Q. Huang,Rashid N. Lui,Yuya Seko,Hirokazu Takahashi,Mazen Noureddin,Ju Dong Yang,Michael B. Wallace,Karn Wijarnpreecha

DOI: https://doi.org/10.14309/ajg.0000000000002819

2024-04-24

The American Journal of Gastroenterology

Abstract:Objective: Obesity is associated with cancer, including gastrointestinal (GI). Data from low (LICs) and lower middle-income countries (MICs) are limited. Methods: We utilized data from the Global Burden of Disease Study (GBD) 2019 to determine the mortality from GI cancer risk from high body mass index (BMI) in these countries. Results: Mortality rates of GI cancers from high BMI increased in LICs and lower MICs, while burdens decreased or remained stable in high and middle-income countries. Discussion: The GI cancer-related burden from high BMI increased in LICs and lower MICs, necessitating a concerted effort to tackle the obesity pandemic.

gastroenterology & hepatology
Obesity and Cancer Risk: Recent Review and Evidence

Karen Basen-Engquist,Maria Chang

DOI: https://doi.org/10.1007/s11912-010-0139-7

2010-11-16

Current Oncology Reports

Abstract:The prevalence of overweight and obesity is increasing worldwide, and the evidence base for a link between obesity and cancer is growing. In the United States, approximately 85,000 new cancer cases per year are related to obesity. Recent research has found that as the body mass index increases by 5 kg/m2, cancer mortality increases by 10%. Additionally, studies of patients who have had bariatric surgery for weight loss report reductions in cancer incidence and mortality, particularly for women. The goal of this review is to provide an update of recent research, with a focus on epidemiologic studies on the link between obesity and cancer. In addition, we will briefly review hypothesized mechanisms underlying the relationship between obesity and cancer. High priorities for future research involve additional work on the underlying mechanisms, and trials to examine the effect of lifestyle behavior change and weight loss interventions on cancer and intermediate biomarkers.

oncology
Obesity And Cancer In Asia

Wanghong Xu,Charles E. Matthews

DOI: https://doi.org/10.1007/978-1-4419-5515-9_3

2010-01-01

Abstract:Obesity has emerged as a major public health challenge for both developed and developing countries. Like more developed countries where obesity represents an increasingly important risk factor for many cancers [1, 2], numerous studies conducted in Asian countries suggest that long-term positive energy balance that leads to elevated adiposity also contributes to the development of many chronic diseases, including the burden associated with a number of different cancer types [3-12]. While the biological mechanisms linking elevated adiposity to cancer do not appear to be markedly different in these populations, there are several unique features of the obesity-cancer association in Asia that are important to understand in relation to cancer prevention and control. First, given the population size and age structure of the larger countries in Asia, the impact of these countries on the worldwide cancer burden is now substantial and in future years will only increase. Second, there are differences in the body size and composition of Asian as compared to Caucasian adults that translate to important differences in association between obesity and cancer, relative to findings from studies conducted among Caucasian adults in the West. In this chapter we will focus on several of these features through review of the epidemiologic evidence available from selected countries in East (e.g., China, Japan, Korea, and Singapore) and Southern Asia (e.g., India, Pakistan).
Global Epidemiology of Early-Onset Liver Cancer Attributable to Specific Aetiologies and Risk Factors from 2010 to 2019.

Chengnan Guo,Zhenqiu Liu,Chunqing Lin,Hong Fan,Xin Zhang,Haili Wang,Xinyu Han,Yi Li,Lina Mu,Shunzhang Yu,Tiejun Zhang

DOI: https://doi.org/10.7189/jogh.13.04167

2023-01-01

Journal of Global Health

Abstract:Background Considering its emergence as a public health concern world-wide, with potential spatial-temporal heterogeneities, we aimed to deter-mine the global burden of early-onset liver cancer attributable to aetiologies and concomitant risk factors.Methods We used data from the Global Burden of Diseases Study 2019 to determine agestandardised disability-adjusted life-year (DALY) rates for early-onset liver cancer by aetiologies and the population DALYs attributable to concomitant risk factors between 2010 and 2019. We also calculated estimated annual percentage changes (EAPCs) to measure temporal trends.Results There were 2.9 million DALYs related to early-onset liver cancer globally in 2019. East Asia contributed over half of DALYs, which increased annually by 1.23% (95% confidence interval (CI) = 0.71, 1.76) between 2010 and 2019. Non-alcoholic steatohepatitis was the only growing aetiology. The proportion of DALYs attributed to metabolic risks increased by 22.50% (95% CI = 14.33, 38.13), while behavioral risks remained stable. Obesity surpassed smoking as the most prevalent nondeterministic aetiological risk factor from 2010 to 2019, while the population DALY attributable to hepati-tis B combined with obesity increased by 29.93% (95% CI = 8.49, 60.77) in the same period, making it the principal joint contributor. Conclusions Early-onset liver cancer poses considerable disability and continues to increase in many regions, especially in East Asia. Metabolic risk factors, particularly when hepatitis B and obesity coexist, are the fastest-growing contributors to this type of cancer. More targeted interventions are imperative to curb the growing burden of early-onset liver cancer due to metabolic risks.
Worldwide Burden Of, Risk Factors For, and Trends in Pancreatic Cancer.

Junjie Huang,Veeleah Lok,Chun Ho Ngai,Lin Zhang,Jinqiu Yuan,Xiang Qian Lao,Kelvin Ng,Charing Chong,Zhi-Jie Zheng,Martin C. S. Wong

DOI: https://doi.org/10.1053/j.gastro.2020.10.007

IF: 29.4

2020-01-01

Gastroenterology

Abstract:BACKGROUND & AIMS: We evaluated global and regional burdens of, risk factors for, and epidemiologic trends in pancreatic cancer among groups of different sexes and ages. METHODS: We used data from the GLOBOCAN database to estimate pancreatic cancer incidence and mortality in 184 countries. We examined the association between lifestyle and metabolic risk factors, extracted from the World Health Organization Global Health Observatory database, and pancreatic cancer incidence and mortality by univariable and multivariable linear regression. We retrieved country-specific age-standardized rates (ASRs) of incidence and mortalities from cancer registries from 48 countries through 2017 for trend analysis by joinpoint regression analysis. RESULTS: The highest incidence and mortality of pancreatic cancer were in regions with very high (ASRs, 7.7 and 4.9) and high human development indexes (ASRs, 6.9 and 4.6) in 2018. Countries with higher incidence and mortality were more likely to have higher prevalence of smoking, alcohol drinking, physical inactivity, obesity, hypertension, and high cholesterol. From 2008 to 2017, 2007 to 2016, or 2003 to 2012, depending on the availability of the data, there were increases in incidence among men and women in 14 (average annual percent changes [AAPCs], 8.85 to 0.41) and 17 (AAPCs, 6.04 to 0.87) countries, respectively. For mortality, the increase was observed in 8 (AAPCs, 4.20 to 0.55) countries among men and 14 (AAPCs, 5.83 to 0.78) countries among women. Although the incidence increased in 18 countries (AAPCs, 7.83 to 0.91) among individuals 50 years or older, an increasing trend in pancreatic cancer was also identified among individuals younger than 50 years and 40 years in 8 (AAPCs, 8.75 to 2.82) and 4 (AAPCs, 11.07 to 8.31) countries, respectively. CONCLUSIONS: In an analysis of data from 48 countries, we found increasing incidence and mortality trends in pancreatic cancer, especially among women and populations 50 years or older, but also among younger individuals. More preventive efforts are recommended for these populations.
The global, regional, and national early-onset colorectal cancer burden and trends from 1990 to 2019: results from the Global Burden of Disease Study 2019

Hongfeng Pan,Zeyi Zhao,Yu Deng,Zhifang Zheng,Ying Huang,Shenghui Huang,Pan Chi

DOI: https://doi.org/10.1186/s12889-022-14274-7

IF: 4.5

2022-10-12

BMC Public Health

Abstract:Abstract Purpose The incidence of early-onset colorectal cancer (EO-CRC), which occurs in people under age 50, has been increasing annually. The aim of this study was to provide an up-to-date estimate of the global EO-CRC burden. Methods We used Global Burden of Disease Study data and methodologies to describe changes in the EO-CRC burden from 1990 to 2019, including incidence, prevalence, mortality, and disability-adjusted life years (DALYs). The driving factors for cancer burden variation were further analyzed using decomposition analysis. Frontier analysis was used to visually demonstrate the potential for burden reduction in each country or region based on their development levels. Results The global EO-CRC incidence more than doubled, increasing from 95,737 (95% uncertainty interval (UI): 90,838–101.042) /100,000 in 1990 to 226,782 (95% UI: 207,495–248,604) /100,000 in 2019. Additionally, related deaths increased from 50,997 (95% UI: 47,692–54,410) /100,000 to 87,014 (95% UI: 80,259–94,339) /100,000, and DALYs increased from 256,1842 (95% UI: 239,4962–2,735,823) /100,000 to 4,297,573 (95% UI: 3,965,485–4,650,790) /100,000. Regarding age-standardized rates, incidence and prevalence increased significantly, while mortality and DALYs rate were basically unchanged. Decomposition analysis showed a significant increase in DALYs in the middle sociodemographic index (SDI) quintile region, in which aging and population growth played a major driving role. Frontier analysis showed that countries or regions with a higher SDI quintile tend to have greater improvement potential. Conclusion The current EO-CRC burden was found to be the greatest in the high-middle SDI quintile region and East Asia, which may need to adjust screening guidelines accordingly and introduce more effective interventions.

public, environmental & occupational health
The Burden of Early-Onset Colorectal Cancer and Its Risk Factors from 1990 to 2019: A Systematic Analysis for the Global Burden of Disease Study 2019

Wan-Jie Gu,Jun-Peng Pei,Jun Lyu,Naohiko Akimoto,Koichiro Haruki,Shuji Ogino,Chun-Dong Zhang

DOI: https://doi.org/10.3390/cancers14143502

2022-07-20

Cancers

Abstract:Background: The incidence of early-onset colorectal cancer (CRC) diagnosed before age 50 has been increasing over the past decades. Hence, we examined the global, regional, and national burden of early-onset CRC and its risk factors from 1990 to 2019. Methods: Using data from the Global Burden of Disease (GBD) Study 2019, we reported the incidence, deaths, and disability-adjusted life-years (DALYs) attributable to the risk factors of early-onset CRC. All estimates were reported with 95% uncertainty intervals (UIs). Results: The global numbers of early-onset CRC for incidence, deaths, and DALYs in 2019 were 225,736 (95% UI, 207,658 to 246,756), 86,545 (80,162 to 93,431), and 4,259,922 (3,942,849 to 4,590,979), respectively. Despite large variations at the regional and national levels, the global incidence rate, death rate, and DALY rate increased from 1990 to 2019. Diets low in milk, diets low in calcium, and alcohol use were the leading risk factors in 2019. From 1990 to 2019, a high body mass index and high fasting plasma glucose ranked remarkably higher among males and females, while smoking and diets low in fiber ranked lower among both sexes, with a more profound change among females. Conclusions: Despite large variations in regional and national levels, the global incidence rate, death rate, and DALY rate increased during the past three decades. These findings may provide policymakers with an accurate quantification of the burden of early-onset CRC and targeted identification of those most at risk to mitigate the burden of early-onset CRC.

oncology
Global incidence trends of early-onset colorectal cancer and related exposures in early-life: an ecological analysis based on the GBD 2019

Ziyang Wang,Weiyuan Yao,Weimiao Wu,Junjie Huang,Yanlei Ma,Chen Yang,Jufang Shi,Jiongxing Fu,Yingying Wang,Martin C S Wong,Wanghong Xu

DOI: https://doi.org/10.3389/fpubh.2024.1367818

2024-06-20

Abstract:Background: The incidence of early-onset colorectal cancer (EOCRC) is increasing globally. This study aims to describe the temporal trends of incidence and explore related risk exposures in early-life at the country level based on the GBD 2019. Methods: Data on the incidence and attributable risk factors of EOCRC were obtained from the GBD 2019. Temporal trends of age-standardized incidence were evaluated by average annual percentage change (AAPC). Early-life exposures were indicated as summary exposure values (SEV) of selected factors, SDI and GDP per capita in previous decades and at ages 0-4, 5-9, 10-14 and 15-19 years. Weighted linear or non-linear regressions were applied to evaluate the ecological aggregate associations of the exposures with incidences of EOCRC. Results: The global age-standardized incidence of EOCRC increased from 3.05 (3.03, 3.07) to 3.85 (3.83, 3.86) per 100,000 during 1990 and 2019. The incidence was higher in countries with high socioeconomic levels, and increased drastically in countries in East Asia and Caribbean, particularly Jamaica, Saudi Arabia and Vietnam. The GDP per capita, SDI, and SEVs of iron deficiency, alcohol use, high body-mass index, and child growth failure in earlier years were more closely related with the incidences of EOCRC in 2019. Exposures at ages 0-4, 5-9, 10-14 and 15-19 years were also associated with the incidences, particularly for the exposures at ages 15-19 years. Conclusion: The global incidence of EOCRC increased during past three decades. The large variations at regional and national level may be related with the distribution of risk exposures in early life.

IgG4-Related Chronic Sclerosing Dacryoadenitis.

Estimation of cancer mortality attributable to excess body weight during 2006-2015 in China

Estimation of Cancer Mortality Attributable to Excess Body Weight During 2006-2015 in China.

Global Trends in Incidence, Death, Burden and Risk Factors of Early-Onset Cancer from 1990 to 2019

Control of oxidative stress in small bowel: relevance to organ preservation.

1706-P: Obesity-Related Cancer Increased Sharply in Young Adults among Chinese Population from 2007 to 2021

Rising incidence of obesity-related cancers among younger adults in China: A population-based analysis (2007-2021)

Estimation of Cancer Incidence and Mortality Attributable to Overweight, Obesity, and Physical Inactivity in China.

The impacts of exposure to risk factors during youth on the increasing global trend of early-onset pancreatic cancer

Plasma fibrinogen and serum C-reactive protein are associated with non-small cell lung cancer.

Obesity, obesities and gastrointestinal cancers

Environmental drivers of the rising incidence of early‐onset colorectal cancer in the United States

Is early-onset cancer an emerging global epidemic? Current evidence and future implications

The Burden of Overweight and Obesity-associated Gastrointestinal Cancers in Low and Lower-middle Income Countries: A Global Burden of Disease 2019 Analysis

Obesity and Cancer Risk: Recent Review and Evidence

Obesity And Cancer In Asia

Global Epidemiology of Early-Onset Liver Cancer Attributable to Specific Aetiologies and Risk Factors from 2010 to 2019.

Worldwide Burden Of, Risk Factors For, and Trends in Pancreatic Cancer.

The global, regional, and national early-onset colorectal cancer burden and trends from 1990 to 2019: results from the Global Burden of Disease Study 2019

The Burden of Early-Onset Colorectal Cancer and Its Risk Factors from 1990 to 2019: A Systematic Analysis for the Global Burden of Disease Study 2019

Global incidence trends of early-onset colorectal cancer and related exposures in early-life: an ecological analysis based on the GBD 2019